NCT01180296View on ClinicalTrials.gov

Oral Progesterone for Prevention of Preterm Birth

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Preterm Birth
Interventions
DRUG

oral micronized progesterone

oral micronized progesterone = 400 mg oral micronized progesterone nightly from 16 to 34 weeks

DRUG

Identical Placebo tablet

Identical Placebo tablet = placebo taking nightly from 16 to 34 weeks

Trial Locations (1)

45409

Miami Valley HospitaL, Dayton

Sponsors
All Listed Sponsors
lead

Fetal Medicine Foundation

OTHER